BWH ID in Primary Care
@bwh_idinpcare
ID: 1185974340744953856
20-10-2019 17:41:42
141 Tweet
407 Followers
7 Following
On the topic of infections after cat bites - check out this amazing cat-infection study aid. Proves what we all know to be true, Dogs >> Cats. Right Sigal Yawetz MD and Paul Sax ? h/t Olivia Kates, MD
Check out this practical approach for recurrent MRSA abscesses. Useful tools for a very challenging clinical syndrome: Jason Frangos anything else to add?
How to determine length of antibiotic therapy? ID trade secrets here😂😂😂 Opportunity to plug Brad Spellberg's tireless work to remind us that shorter is better! bradspellberg.com/shorter-is-bet…
Next up Jake Johnson on TB for the PCP. That positive PPD must be due to the history of BCG vaccine, right? Wrong! In 240,203 BCG-vaccinated infants, only 56/5639 (1%) were TST-positive if tested >=10 years after BCG. Classic study here: pubmed.ncbi.nlm.nih.gov/17131776/
What do you use to treat LTBI? In the absence of drug-drug interactions or contraindications, Jake Johnson (and all of his admirers) uses rifampin x4 months over INH in most cases of LTBI. See practice-changing study here: nejm.org/doi/full/10.10…
Thanks to Dr Sarah Hammond for reviewing infectious complications of non-HIV related immunosuppression, here highlighting the markedly elevated risk of zoster seen with JAK inhibitors such as tofacitinib. Speaking today in our course BWH ID in Primary Care
Antibiotic allergy guru, Paige Wickner kicks off our session today. Your patient has a history of PCN allergy... Very important distinction: what is the difference between antibiotic "Challenge" and antibiotic "Desensitization"?
A patient comes in to discuss #PrEP for HIV. Do you feel prepared? This afternoon Sigal Yawetz MD makes the case for HIV #PrEP in primary care. How to chose a regimen?
Yesterday Sigal Yawetz MD on knowns / unknowns in management of mild-to-moderate #COVID19 & generalizing from study results: treating at risk patients, do vaccinated patients still benefit, the rebound problem, managing profoundly immunocompromised patients, long COVID, and more...